Minnesota 12-year-old is first in new trial of drug to treat rare, crippling disorder

AI Briefing

• – Minnesota 12-year-old is first in new trial of drug to treat rare, crippling disorder
• – Gillette Children’s Specialty Healthcare in St. Paul was first to set up special program for providing still-experimental drug against Duchenne muscular dystrophy
• – The drug is being tested for its effectiveness in treating the debilitating genetic disorder